Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection

Journal of Infectious Diseases

Volumn 173, Issue 2, 1996, Pages 349-354

  Koot, Maarten ^a   Angelique ^b   Van 't Wout, B ^b   Kootstra, Neeltje A ^b   De Goede, Ruud E Y ^b   Tersmette, Matthijs ^b   Schuitemaker, Hanneke ^b  

^a CENTRAL LABORATORY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIREMIA; VIRUS CELL INTERACTION;

EID: 19144365480     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.2.349     Document Type: Article

References (31)

1. Kaslow RA, Duquesnoy R, Van Raden M, et al. A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. Lancet 1990;335:927-30.
2. Klein MR, Kect IPM, D'Amaro J, et al. Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men. J Infect Dis 1994;169:1244-9.
3. Webster A, Lee CA, Cook DG, et al. Cytomegalovirus infection and progression towards AIDS in hemophiliacs with human immunodeficiency virus infection. Lancet 1989;2:63-9.
4. + lymphocytes by the AIDS-associated mycoplasma. Science 1991;251:1074-6.
5. Schuitemaker H, Koot M, Kootstra NA, et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J Virol 1992;66:1354-60.
6. + cell decline during progression to AIDS correlates with HIV-1 phenotype. AIDS 1992;6:665-9.
7. + cell depletion and progression to AIDS. Ann Intern Med 1993;118:681-8.
8. Coombs RW, Collier AC, Allain JP, et al. Plasma viremia in human immunodeficiency virus infection. N Engl J Med 1989;321:1626-31.
9. Ho DD, Moudgil T, Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 1989;321:1621-5.
10. + cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men. J Infect Dis 1988;158:615-22.
11. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36(suppl):1S-15S.
12. Fischl MA, Richman DD, Hansen N, et al. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. Ann Intern Med 1990;112:727-37.
13. gag. Virology 1989;171:149-55.
14. Tersmette M, De Goede REY, Al BJM, et al. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol 1988;62:2026-32.
15. Schnittman SM, Psallidopoulos MC, Lane HC, et al. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 1989;245:305-8.
16. Tersmette M, Lange JMA, De Goede REY, et al. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet 1989;1:983-5.
17. + T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann Intern Med 1990;113:438-43.
18. + T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1 infected individuals. J Virol 1993;67:1772-7.
19. Piatak M Jr, Saag MS, Yang LC, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-54.
20. Bozzette SA, McCutchan JA, Spector SA, Wright B, Richman DD. A cross-sectional comparison of persons with syncytium- and non-syncytium-inducing human immunodeficiency virus. J Infect Dis 1993;168:1374-9.
21. Harper ME, Marselle LM, Gallo RC, Wong-Staal F. Detection of lymphocytes expressing HTLV-III in lymph nodes and peripheral blood from infected persons by in situ hybridization. Proc Natl Acad Sci USA 1986;83:772-6.
22. Ameisen JC, Capron A. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today 1991;12:102-5.
23. Kaneshima H, Su L, Bonyhadi ML, Connor RI, Ho DD, McCune JM. Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of SCID-hu mouse. J Virol 1994;68:8188-92.
24. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
25. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-22.
26. Anand R, Reed C, Forlenza S, Siegal F, Cheung T, Moore J. Non-cytocidal natural variants of human immunodeficiency virus isolated from AIDS patients with neurological disorder. Lancet 1987;2:234-8.
27. Sodroski J, Goh WC, Rosen C, Campbell K, Haseltine WA. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature 1986;322:470-4.
28. Clavel F, Chameau P. Fusion from without directed by human immunodeficiency virus particles. J Virol 1994;68:1179-85.
29. Shafer RW, Aguiniga E, Merigan TC. Quantitative analysis of syncytium inducing and non-syncytium-indueing virus in patients infected with human immunodeficiency virus type I. J Clin Microbiol 1995;33:212-4.
30. Daar ES, Chernyavskiy T, Zhao JQ, Krogstad P, Chen ISY, Zack JA. Sequential determination of viral load and phenotype in human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 1995;11:3-9.
31. Simmonds P, Zhang LQ, McOmish F, Balfe P, Ludlam CA, Brown AJL. Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis. J Virol 1991;65:6266-76.